Come On, CMS—What’s Up With That?
The Association for Accessible Medicines (AAM) recently mentioned a report titled “Study: 57 Percent of Covered Generic Drugs Not on Part D Generic Tiers in 2025” (here), conducted by Avalere, that raises serious questions regarding the Centers for Medicare and Medicaid Services (CMS) placement of many generic drugs on higher tiers, which are usually reserved for brand-name […]
